Dynamic and Static Exercises Differentially Affect Plasma Cytokine Content in Elite Endurance- and Strength-Trained Athletes and Untrained Volunteers

Dettagli Bibliografici
Parent link:Frontiers in Physiology
Vol. 8.— 2017.— [article 35, 10 p.]
Ente Autore: Национальный исследовательский Томский политехнический университет (ТПУ) Институт социально-гуманитарных технологий (ИСГТ) Кафедра физической культуры (ФК)
Altri autori: Kapilevich L. V. Leonid Vladimirovich, Zakharova A. N. Anna, Kabachkova A. V. Anastasia, Kironenko T. A. Tatyana, Orlov S. N. Sergey Nikolaevich
Riassunto:Title screen
Patients with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) have high risk of microcirculation complications and microangiopathies. An increase in thrombogenic risk is associated with platelet hyperaggregation, hypercoagulation, and hyperfibrinolysis. Factors leading to platelet activation in MetS and T2DM comprise insulin resistance, hyperglycemia, non-enzymatic glycosylation, oxidative stress, and inflammation. This review discusses the role of nitric oxide (NO) in the regulation of platelet adhesion and aggregation processes. NO is synthesized both in endotheliocytes, smooth muscle cells, macrophages, and platelets. Modification of platelet NO-synthase (NOS) activity in MetS patients can play a central role in the manifestation of platelet hyperactivation. Metabolic changes, accompanying T2DM, can lead to an abnormal NOS expression and activity in platelets. Hyperhomocysteinemia, often accompanying T2DM, is a risk factor for cardiovascular accidents. Homocysteine can reduce NO production by platelets. This review provides data on the insulin effects in platelets. Decrease in a number and sensitivity of the insulin receptors on platelets in T2DM can cause platelet hyperactivation. Various intracellular mechanisms of anti-aggregating insulin effects are discussed. Anti-aggregating effects of insulin are mediated by a NO-induced elevation of cGMP and upregulation of cAMP- and cGMP-dependent pathways. The review presents data suggesting an ability of platelets to synthesize humoral factors stimulating thrombogenesis and inflammation. Proinflammatory cytokines are considered as markers of T2DM and cardiovascular complications and are involved in the development of dyslipidemia and insulin resistance. The article provides an evaluation of NO-mediated signaling pathway in the effects of cytokines on platelet aggregation. The effects of the proinflammatory cytokines on functional activity of platelets are demonstrated.
Lingua:inglese
Pubblicazione: 2017
Soggetti:
Accesso online:https://doi.org/10.3389/fphys.2017.00035
Natura: Elettronico Capitolo di libro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=656039

MARC

LEADER 00000naa0a2200000 4500
001 656039
005 20250401154712.0
035 |a (RuTPU)RU\TPU\network\22384 
090 |a 656039 
100 |a 20171019d2017 k||y0rusy50 ba 
101 0 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Dynamic and Static Exercises Differentially Affect Plasma Cytokine Content in Elite Endurance- and Strength-Trained Athletes and Untrained Volunteers  |f L. V. Kapilevich [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 50 tit.] 
330 |a Patients with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) have high risk of microcirculation complications and microangiopathies. An increase in thrombogenic risk is associated with platelet hyperaggregation, hypercoagulation, and hyperfibrinolysis. Factors leading to platelet activation in MetS and T2DM comprise insulin resistance, hyperglycemia, non-enzymatic glycosylation, oxidative stress, and inflammation. This review discusses the role of nitric oxide (NO) in the regulation of platelet adhesion and aggregation processes. NO is synthesized both in endotheliocytes, smooth muscle cells, macrophages, and platelets. Modification of platelet NO-synthase (NOS) activity in MetS patients can play a central role in the manifestation of platelet hyperactivation. Metabolic changes, accompanying T2DM, can lead to an abnormal NOS expression and activity in platelets. Hyperhomocysteinemia, often accompanying T2DM, is a risk factor for cardiovascular accidents. Homocysteine can reduce NO production by platelets. This review provides data on the insulin effects in platelets. Decrease in a number and sensitivity of the insulin receptors on platelets in T2DM can cause platelet hyperactivation. Various intracellular mechanisms of anti-aggregating insulin effects are discussed. Anti-aggregating effects of insulin are mediated by a NO-induced elevation of cGMP and upregulation of cAMP- and cGMP-dependent pathways. The review presents data suggesting an ability of platelets to synthesize humoral factors stimulating thrombogenesis and inflammation. Proinflammatory cytokines are considered as markers of T2DM and cardiovascular complications and are involved in the development of dyslipidemia and insulin resistance. The article provides an evaluation of NO-mediated signaling pathway in the effects of cytokines on platelet aggregation. The effects of the proinflammatory cytokines on functional activity of platelets are demonstrated. 
461 |t Frontiers in Physiology 
463 |t Vol. 8  |v [article 35, 10 p.]  |d 2017 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a спорт высших достижений 
610 1 |a спортсмены 
610 1 |a физические упражнения 
610 1 |a цитокины 
610 1 |a плазма 
610 1 |a элитный спорт 
610 1 |a выносливость 
610 1 |a силовые тренировки 
701 1 |a Kapilevich  |b L. V.  |c specialist in the field of physical culture and sports  |c Professor of Tomsk Polytechnic University, Doctor of medical sciences  |f 1963-  |g Leonid Vladimirovich  |3 (RuTPU)RU\TPU\pers\33522  |9 17190 
701 1 |a Zakharova  |b A. N.  |g Anna 
701 1 |a Kabachkova  |b A. V.  |g Anastasia 
701 1 |a Kironenko  |b T. A.  |g Tatyana 
701 1 |a Orlov  |b S. N.  |g Sergey Nikolaevich 
712 0 2 |a Национальный исследовательский Томский политехнический университет (ТПУ)  |b Институт социально-гуманитарных технологий (ИСГТ)  |b Кафедра физической культуры (ФК)  |3 (RuTPU)RU\TPU\col\22621 
801 2 |a RU  |b 63413507  |c 20171019  |g RCR 
856 4 |u https://doi.org/10.3389/fphys.2017.00035 
942 |c CF